ERBB2 and breast carcinoma: This is probably the first demonstration that a protective immune response against HER-2 can be elicited in hamsters by EC-TM DNA-vax as in mice transgenic for the rat HER-2 that develop mammary carcinomas (Rovero et al, 2000; Quaglino et al, 2004a).